SECTION I: Testing
1 |
Has the R & D result been tested? | |
YES | Pilot applications for services on food traceability and prototypes for products | |
NO |
If yes:
1a |
In what mode has the result been tested?
• Prototype • Pilot Application • Alpha/BETA testing |
|
Prototypes
Pilot applications |
||
1b |
Please describe and discuss the testing results | |
Prototypes : DNA probes capable of identifying more than 20 different plant species in food and feed have been produced and successfully tested. Pilot applications : Traceability services for the presence and identification of plant species in feed and food have been set up and provided to some client company. |
If no:
1c |
Describe what type of testing does the R&D result need? | |
1d |
What is the time needed for testing? | |
1e |
What is the cost needed for testing? | |
SECTION 2: Current Stage of Development
2a |
To what extent does the development team have technical resources for supporting the production of a new product? (Researchers, human resources, hardware, etc. ) |
For genetics, products and services are the result of innovative procedures set up in the lab of Dr. Breviario at CNR Milan. Procedures are protected by a European patent and an international PCT pending patent. Methods just wait the phase of launch that means coupling with market demand, in big figures. In such a perspective, they need to be brought to a further step of an efficient automation. For metabolomics, services are based on home-made protocols. Developed by Dr. Consonni at CNR Milan, they just need instrument implementation in case of large demand. |
2b |
What are the technical issues that need to be tackled for full deployment, if needed? |
No major tasks. For genetics: automation in the production of DPC code and use of newly developed probes in RT-PCR protocols. For metabolomics: none. |
2c |
What additional technical resources are needed for the production of this new product? |
For genetics: a DNA analyzer and an RT-PCR machine.
For metabolomics: none. |
2d |
Overall assessment of the current stage of technical development. |
For both genetics and metabolomics , business can start and grow together with the increase of the demand and the implementation of the instruments required for diagnosis |
SECTION 3: Deployment
3a |
Define the demands for large scale production in terms of |
|
|
Reagents and disposables for molecular biology and biochemistry | |
|
|
DNA analyzer
RT-PCR machine |
|
|
|
3 young researchers, 1 technician |
SECTION 4: Overall Assessment
1 |
What is you overall assessment of the technical feasibility of the research result? |
Sub-optimal. There are margins of improvements that relates with the need for automation |
KEYWORDS QUANTITATIVE ASSESSMENT (0-5).
Adequacy of testing activity undertaken so far |
1 |
2 |
3 |
4 |
5 |
Adequacy and availability of technical resources of the development team |
1 |
2 |
3 |
4 |
5 |
Current development stage |
1 |
2 |
3 |
4 |
5 |
Overall technical feasibility |
1 |
2 |
3 |
4 |
5 |